- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New brachy product begins use
The first patient has been treated with the Flexitron brachytherapy product, available from Nucletron and its developer, Isodose Control.
New brachy product begins use
The first patient has been treated with the Flexitron brachytherapy product, available from Nucletron and its developer, Isodose Control. The 40-channel afterloader was applied in the treatment of breast cancer at the Cancer Specialists of Oklahoma in Oklahoma City. Flexitron was recently integrated into Nucletron's offering of high dose rate brachytherapy afterloaders, applicators, and treatment planning solutions Sept. 1 when Nucletron and Isodose Control forged a partnership to serve the global brachytherapy marketplace. Nucletron is framing the newly introduced product as the next generation of afterloading platforms for cancer treatment. The brachytherapy product employs a 40-channel radiation delivery system with DICOM compatibility and includes dual radiation source capabilities and multiple isotope compatibility.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
